– the leading provider of online annual reports to individual and institutional investors.

Palatin Technologies Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops peptide, peptide mimetic, and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems in the United States.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports